2BB score and signals
Bolt Biotherapeutics, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 2 | Very Weak |
| Quality | 40 | Normal |
| Risk | 69 | High |
Company facts
| Headquarters | Redwood City, California, United States |
| Founded | 2015 |
| Employees | 23 |
| 52-week range | $3.10 – $7.09 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-10 | — | -4.0834 | — | $52,356.00 |
| 2026-11-10 | — | -3.9678 | — | $69,696.00 |
| 2026-08-12 | — | -3.4544 | — | $510,000.00 |
| 2026-05-12 | -4.31 | -2.907 | $26,000.00 | $1.53M |
Related companies
